Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer.
Durante G, Broseghini E, Comito F, Naddeo M, Milani M, Salamon I, Campione E, Dika E, Ferracin M. Durante G, et al. Among authors: ferracin m. Expert Rev Mol Diagn. 2022 Mar;22(3):305-318. doi: 10.1080/14737159.2022.2049243. Epub 2022 Mar 11. Expert Rev Mol Diagn. 2022. PMID: 35235479 Review.
Absolute quantification of cell-free microRNAs in cancer patients.
Ferracin M, Lupini L, Salamon I, Saccenti E, Zanzi MV, Rocchi A, Da Ros L, Zagatti B, Musa G, Bassi C, Mangolini A, Cavallesco G, Frassoldati A, Volpato S, Carcoforo P, Hollingsworth AB, Negrini M. Ferracin M, et al. Oncotarget. 2015 Jun 10;6(16):14545-55. doi: 10.18632/oncotarget.3859. Oncotarget. 2015. PMID: 26036630 Free PMC article.
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
Bononi I, Comar M, Puozzo A, Stendardo M, Boschetto P, Orecchia S, Libener R, Guaschino R, Pietrobon S, Ferracin M, Negrini M, Martini F, Bovenzi M, Tognon M. Bononi I, et al. Among authors: ferracin m. Oncotarget. 2016 Dec 13;7(50):82700-82711. doi: 10.18632/oncotarget.12408. Oncotarget. 2016. PMID: 27716620 Free PMC article.
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts.
Todeschini P, Salviato E, Paracchini L, Ferracin M, Petrillo M, Zanotti L, Tognon G, Gambino A, Calura E, Caratti G, Martini P, Beltrame L, Maragoni L, Gallo D, Odicino FE, Sartori E, Scambia G, Negrini M, Ravaggi A, D'Incalci M, Marchini S, Bignotti E, Romualdi C. Todeschini P, et al. Among authors: ferracin m. Cancer Lett. 2017 Mar 1;388:320-327. doi: 10.1016/j.canlet.2016.12.017. Epub 2016 Dec 22. Cancer Lett. 2017. PMID: 28017893
176 results